Not yet taking people in Németország1. fázis
A phase I, open-label, dose-escalation, safety, pharmacokinetic/-dynamic and clinical activity study of p38α inhibitor Skepinone-L to enhance therapeutic efficacy of Sorafenib in advanced hepatocellular carcinomas of non-viral origin
Key facts
- Where
- Tuebingen, NémetországSee the site
- Phase
- 1. fázis
Where in Németország
- Universitaetsklinikum Tuebingen AöRTuebingen, NémetországToborzás még nem indult
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Universitaetsklinikum Tuebingen AöR
- Trial code
- EU 2024-511516-24-00
- Record updated
- 2026. szeptember 29.